Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on May 15, 2025

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Emrosi™ commercial launch initiated for the treatment of inflammatory lesions of rosacea in adults Fortress subsidiary Checkpoint Therapeutics to be acquired by Sun Pharma; special meeting of Checkpoint stockholders to approve the transaction to take place …

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates SAN DIEGO, …

Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights
– 446 participants completed the brilaroxazine long-term open-label extension (OLE) trial with 156 completing one-year and 301 completing six months of treatment – – Full data set from RECOVER OLE highlighting clinical response, safety, efficacy, adherence …

Veeco Announces Upcoming Investor Events
PLAINVIEW, N.Y., May 15, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (NASDAQ: VECO) today announced management is scheduled to participate in the following investor events: TD Cowen’s 53rd Annual Technology, Media …

iPower Reports Fiscal Third Quarter 2025 Results
RANCHO CUCAMONGA, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced its financial results for the fiscal third quarter …

AvePoint to Participate in June Investor Conferences
JERSEY CITY, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the William Blair 45th …

vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
Ongoing screening in CATT1 Phase 3 trial evaluating cadisegliatin in patients with type 1 diabetes (T1D) Topline Phase 3 data for cadisegliatin expected in 2H 2026 HIGH POINT, N.C., May 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a …

Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …

Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …

374Water Reports First Quarter 2025 Financial Results
Multiple Deployments Scheduled throughout 2025 to Showcase AirSCWO Technology Launched Waste Destruction Services and Signed RCRA Part B TSDF Partner Agreement to Expand Onsite Operations New Executive Team and Director Appointments to Drive Commercial …

Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE …

Intermap Announces First Quarter 2025 Results
Company reports first quarter 2025 revenue growth of 153% with 28% pro-forma adjusted EBITDA margin Confirms projected 2025 revenue of $30–35 million and 28% EBITDA margin Conference call today at 5:00 pm ET to discuss results DENVER, May 15, 2025 (GLOBE …

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2025
- VCN-01 alcanza los criterios de valoración primarios de eficacia y seguridad para el adenocarcinoma pancreático ductal en el ensayo clínico de Fase 2b VIRAGE - - El 8 de mayo de 2025 se cerró una oferta pública que aumentó el saldo de caja de la empresa …

Eric Branderiz Joins Symbotic’s Board of Directors
WILMINGTON, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the election of Eric Branderiz to its Board of Directors, effective May 14, 2025. Mr. …

Dianabol (Dbol) For Sale 2025: Best Legal Dbol Pills, Cycles & Stacking Guide
New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- Dianabol, renowned for its capacity to induce significant muscle hypertrophy, has also been linked to adverse effects such as jaundice, hormonal disruptions, and depressive symptoms. Consequently, …

OMNIQ Reports $19.9 Million Revenue in the First Quarter 2025
SALT LAKE CITY, May 15, 2025 (GLOBE NEWSWIRE) -- OMNIQ CORP. (OTCMKTS: OMQS) ("omniQ" or "the Company"), reports a first quarter 2025 revenue of $19.9 million, which signifies an 8.7 percent increase Year-over-Year. FINANCIAL SUMMARY In Q1 2025, the …

Sword Group: Notification of Threshold Crossing
By letter received on May 13, 2025, the simplified joint-stock company Indépendance AM (20 avenue Franklin D. Roosevelt, 75008 Paris), acting on behalf of funds under its management, declared that on May 8, 2025, it had crossed upwards the thresholds of 5% …

Sword Group : Déclaration de Franchissement de Seuil
Par courrier reçu le 13 mai 2025, la société par actions simplifiée Indépendance AM (20 avenue Franklin D. Roosevelt, 75008 Paris), agissant pour le compte de fonds dont elle assure la gestion, a déclaré avoir franchi en hausse, le 8 mai 2025, les seuils …

Bitcoin & Solana To Surge To $400k & $420 Respectively? Unlock Passive Income: Bitcoin Cloud Mining with VNBTC Targets the Next Crypto Surge
London,UK, May 15, 2025 (GLOBE NEWSWIRE) -- The global crypto market recorded a radical shift in the past month: Bitcoin soared above $100K before meeting resistance at $105 K. Solana broke out from below $130 in mid-April to $180. This super surge is …

Best SARMs For Sale: Buy Legal SARMs For Bodybuilding & Cutting Cycles - Crazybulk
New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- Introduction In today’s fitness landscape, many are seeking faster, safer paths to noticeable physique changes. Whether it's for trimming body fat or sculpting lean muscle, SARMs—short for Selective …